Central Europe Catheters Market Size, Share & COVID-19 Impact Analysis, By Product Type (Indwelling Catheters, Intermittent Catheters, and External Catheters), By Material (Latex, Silicone, and Others), By Type (Male and Female), By End-user (Hospitals & ASCs, Clinics, Long-term Care Centers, Homecare Settings, and Others), and Regional Forecast, 2023-2030

The Central Europe catheters market size was valued at USD 515.3 million in 2022. The market is projected to grow from USD 545.8 million in 2023 to USD 856.7 million by 2030, exhibiting a CAGR of 6.7% during the forecast period.

A urinary catheter is a device that is used to drain the bladder when the person is either not able to control their urine (urinary incontinence) or is not able to empty their bladder (urinary retention). Diseases, such as diabetes, Alzheimer’s, stroke, spinal injury, and brain tumor can impact the nerve signals controlling the bladder, thereby causing urinary incontinence. Therefore, the increasing prevalence of these diseases is fueling the demand for these devices.

• For instance, according to the data published by the National Center for Biotechnology Information (NCBI) in 2021, around 14.6% to 25.4% of the population in Poland suffered from urinary incontinence.

Due to the rising burden of the above-mentioned diseases, the prevalence of urinary incontinence has also increased significantly. The rising incidence of urinary incontinence has paved the way for increasing awareness regarding the disease and has also fueled its diagnosis rate. These factors have increased the demand for urinary catheterization for effectively managing the disease, thereby fueling the Central Europe catheters market growth.

COVID-19 IMPACT

Reduced Number of Patients Visiting Doctor’s Clinic for Urinary Incontinence Slowed Market Growth

During the COVID-19 pandemic, the Central Europe catheters market experienced a slow growth in terms of revenue. This was due to supply chain disruptions and lower number of patients visiting the doctor’s clinic for urinary incontinence treatment. Moreover, the postponement of non-emergency surgeries, including urological surgeries, to control the spread of the virus, also impacted the market growth. The Organization for Economic Co-operation and Development (OECD) stated that there was a huge decline in several urological procedures in many European countries during the COVID-19 pandemic.

• For instance, according to the data published by the Organization for Economic Co-operation and Development (OECD), the total number of procedures decreased by approximately 13.5% in Austria in 2020.

Moreover, the market players also experienced slow growth in their revenue due to low demand for urinary catheterization. For instance, in 2020, B. Braun SE generated a revenue of USD 1,286.3 million in 2020 from its Avitum segment, experiencing a slow growth of 1% in its revenue from the previous year.

However, the market experienced significant growth in 2021 and 2022 due to rise in the number of urological procedures and increased demand for catheterization devices. Moreover, market players also experienced significant growth in their revenues post-pandemic. For instance, B. Braun SE generated a revenue of USD 1,926.8 million in 2021 from its Avitum segment, experiencing a significant growth of 49.8% from the previous year.

Central Europe Catheters Market Trends

Rising Number of Surgical Procedures in Central European Countries

Urinary catheterization is most commonly and frequently used in patients undergoing surgeries to prevent bladder distention and urinary incontinence in patients who are not able to walk or are anaesthetized. These devices help in the measurement of urine output during and after the surgery, which acts as an indirect marker of the renal, cardiovascular, and fluid status of the patient. The increasing prevalence of chronic diseases and rising awareness regarding the treatment of these diseases are boosting the number of hospital admissions and surgeries performed to treat these diseases.

Urinary catheterization devices are widely used in hospitals and ambulatory surgical centers after any surgery for patients who are not in a condition to walk or are bedridden. Therefore, the increasing number of surgical procedures in the region is fueling the demand for these devices.

• For instance, according to the Federal Statistical Office (Destatis), there were around 220,700 caesarian surgeries conducted in 2020 in Germany, experiencing an increase of 5.4% from 2010.

Therefore, the increasing prevalence of chronic diseases and rising number of surgeries will boost the demand for these catheterization devices, thereby fueling the market growth.

Central Europe Catheters Market Growth Factors

Rising Geriatric Population to Fuel Demand for Urinary Catheterization

Geriatric population has been growing at a significant rate in Central European countries. With growing age, bladder problems, such as urine leakage, urine retention, Benign Prostate Hyperplasia (BPH), and other issues have become more common.

• According to the World Bank Group, in 2022, the population in Germany aged 65 years and above accounted for 22% of the total population. Similarly, in Hungary and Poland, the geriatric population accounted for 20% and 19% of the total population, respectively.


• The National Center for Biotechnology Information (NCBI) published a research study in 2022 consisting of 2,612 male and 3,393 female respondents. Out of these respondents, 66.7% of the female population and 31.2% of the male population suffering from urinary incontinence were aged 80 years and above.


• Also, as per the data published by Sage Journals in 2021, the incidence of BPH in Eastern Europe was 629.82 per 100,000 persons. The incidence of the same disease was about 341.13 per 100,000 persons in Central Europe in 2019.

Urinary incontinence and BPH are more common among the geriatric population. For instance, as per the data published by the National Center for Biotechnology Information (NCBI) in 2020, urinary continence is prevalent in around 11-34% of the male population and 17-55% of the female population across the world. Therefore, the increasing geriatric population is expected to fuel the demand for urinary catheterization in the Central European region.

RESTRAINING FACTORS

Presence of Alternate Options for Managing Urinary Incontinence to Limit Market Growth

Market players are focusing on the commercialization of new technologically advanced urinary catheterization devices to manage urinary continence effectively. However, the presence of alternate options, such as absorbent pads, slings, and others has limited the adoption of these devices. Also, the preference for these devices among women suffering from urinary incontinence is low due to the availability of other options.

Furthermore, the manufacturers of absorbent pads and slings are focusing on the launch of advanced products to manage urinary incontinence effectively. This factor is also limiting the adoption of these devices in the market.

• For instance, in October 2020, Essity, a hygiene and health company, launched TENA SmartCare, a reusable digital sensor for improved incontinence care. The sensor is attached to the outside of the absorbent pads to track the degree of urine saturation.

Moreover, the increasing risk of Catheter-Associated Urinary Tract Infections (CAUTI) is also limiting its adoption among the patient population. For instance, as per the research study published by German Medical Publishers GmbH in 2020, urinary tract infections accounted for around 21.6% of all nosocomial infections in Germany. Moreover, 60% of the nosocomial urinary tract infections was caused by catheters. The rising prevalence of CAUTI, along with the availability of alternate options for these devices, may limiting the use of these devices among the patient population, thereby negatively impacting the market growth.

Central Europe Catheters Market Segmentation Analysis

By Product Type Analysis

Increasing Awareness of Intermittent Catheters Fueled Their Demand in the Market

On the basis of product type, the market is segmented into indwelling catheters, intermittent catheters, and external catheters.

The intermittent catheters segment dominated the market in 2022 due to various benefits associated with their use, such as reduced risk of urinary tract infection and better autonomy. Moreover, the increasing focus of healthcare professionals on reducing Catheter-Associated Urinary Tract Infection (CAUTI) is also fueling the demand for this product as with these devices, the chances of CAUTI are less. For instance, as per the data published by the National Center for Biotechnology Information (NCBI) in 2023, intermittent catheterization is considered the gold standard as the chances of urinary tract infection are low while using these devices as compared to indwelling catheterization.

Moreover, the indwelling catheters segment is expected to record a significant CAGR during the forecast period. The growth of the segment is attributed to the rising number of hospital admissions and increasing number of caesarian and orthopedic surgeries in the Central European countries.

By Material Analysis

Increasing Focus of Market Players on Launch of Foley Catheters Augmented Use of Latex

Based on material, the market is segmented into latex, silicone, and others.

The latex segment dominated the market in 2022 and is expected to record a significant CAGR during the forecast period. Latex is mostly used as a material for Foley catheters, and these devices are majorly used in hospitals, post-surgery. Therefore, the increasing number of surgeries in hospitals will fuel the demand for latex catheters. Moreover, the increasing focus of market players on getting regulatory approvals for their technologically advanced products will also fuel the segment’s growth.

• For instance, in January 2023, Bactiguard AB received its first MDR (Medical Device Regulations 2017/745) approval for its latex BIP Foley catheter. It is an indwelling catheter with advanced infection-prevention technology.

Moreover, the silicone segment is expected to register a significant CAGR during the forecast period due to rising awareness regarding the use of intermittent urinary catheterization devices in homecare settings.

By Type Analysis

Increasing Prevalence of Chronic Diseases Among Male Population Boosts Product Use

Based on type, the market is bifurcated into male and female.

The male segment dominated the market in 2022. The segment’s dominance is attributed to the higher preference of the male population toward these products as compared to the female population. Furthermore, the increasing prevalence of neurological disorders, diabetes, and Benign Prostatic Hyperplasia (BPH) among the male population is also fueling the segment’s growth.

• For instance, as per a research study report published by Elsevier Ltd. in 2022, Benign Prostatic Hyperplasia (BPH) affected around 2.97 million people in Central Europe in 2019, experiencing an increase of 32.9% from 2000.

The female segment is expected to record a moderate CAGR during the forecast period. The growth of the segment is attributed to the high number of caesarian surgeries conducted in the region.

By End-user Analysis

Hospitals & ASCs Emerge to be a Major End-Users Due to Increasing Number of Patients Visiting These Medical Centers for Treatment

On the basis of end-user, the market is segmented into hospitals & ASCs, clinics, long-term care centers, homecare settings, and others.

The hospitals & ASCs segment dominated the market in 2022 due to the availability of a large number of hospitals and increasing patients' preference for hospitals as they can get diagnosed and treated for various urological diseases at the same place.

• For instance, as per the data published by Statistisches Bundesamt (Destatis), in 2022, there were around 1,893 hospitals in Germany, 480,382 hospital beds, and around 16,802,693 patients visiting hospitals. The average hospital stay was 7.2 days, with 69% bed occupancy rate.

Moreover, the homecare settings segment is expected to record a significant CAGR during the forecast period. The growth of the segment is attributed to the increasing prevalence of neurological disorders and diabetes in the Central European countries, which is fueling the demand for these products in homecare settings.

The long-term care centers segment is expected to register a substantial CAGR during the forecast period. The increasing percentage of the geriatric population in the region is responsible for the segment’s growth.

REGIONAL INSIGHTS

Strong Presence of Key Players in Rest of Central Europe is Responsible for Market’s Regional Dominance

The Rest of Central Europe market generated a revenue of USD 439 million in 2022 accounting for maximum share in terms of revneue as compared to other countries in the region. The dominance of the rest of Central Europe in the market is due to the strong presence of market players, such as UROMED Kurt Drews KG and B. Braun SE and strong awareness about urinary incontinence.

Moreover, Poland generated the second-largest market value in 2022. This was due to the rising prevalence of urinary incontinence and other chronic diseases, such as cancer in the country.

• For instance, as per the data published by the Global Cancer Observatory in 2020, in the past five years, cancer was prevalent in 586,941 individuals in Poland.

The catheter market in Austria and Hungary is expected to record a substantial CAGR during the forecast period. The market’s growth in these countries is due to the increasing prevalence of urinary incontinence and rising awareness regarding catheterization devices.

List of Key Companies in Central Europe Catheters Market

Increasing Focus of Market Players on Mergers & Acquisitions to Enhance their Product Portfolio Will Fuel their Market Share

Coloplast Corp., B. Braun SE, and Convatec Group PLC are among the key players that accounted for a significant Central Europe catheters market share in 2022. The dominance of these companies in the market is attributed to their strong product portfolio, new product launches, and strategic initiatives to maintain their position in the market.

• For instance, in April 2020, Coloplast Corp. launched SpeediCath Flex Set, a new product within continence care. It is an all-in-one solution with a soft catheter with triple action coating technology, a dry sleeve, a flexible tip, and a dry-to-touch urine drainage bag attached.

Moreover, other players, such as Sterimed Group, Cook, and Hollister Incorporated are emphasizing on new product launches and expansion of their manufacturing facilities in the Central European region to strengthen their market positions.

LIST OF KEY COMPANIES PROFILED:

• UROMED Kurt Drews KG (Germany)


• Medtronic (Ireland)


• Coloplast Corp. (Denmark)


• B. Braun SE (Germany)


• Teleflex Incorporated (U.S.)


• Cook (U.S.)


• Boston Scientific Corporation (U.S.)


• Cardinal Health (U.S.)


• Hollister Incorporated (U.S.)


• Sterimed Group (India)

KEY INDUSTRY DEVELOPMENTS:

• October 2023 – Teleflex Incorporated acquired Palette Life Sciences AB to add Barrigel, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolio.


• July 2023 – Cook partnered with Purdue University, the Indiana University School of Medicine to improve medical care for pediatric patients.


• January 2023 – Cardinal Health partnered with Palantir Technologies Inc. to improve the digitalization within healthcare systems.


• September 2022 – B. Braun SE acquired Clik-FIX catheter securement devices from Starboard Medical to offer advanced products in its product portfolio.


• January 2022 – Otsuka Pharmaceutical Factory, Inc. launched Actreen, an intermittent urological catheter consisting of a catheter (tube) and connector to be used during self-catheterization, for urinary incontinence. The product facilitates ease of opening and handling among patients.

REPORT COVERAGE

The report provides a detailed competitive landscape. It also includes key insights, such as top industry developments covering partnerships, mergers, and acquisitions. Additionally, it focuses on crucial aspects, such as new product launches in the market. Furthermore, the report covers the regional analysis of different segments, profiles of key market players, market trends, and the impact of COVID-19 on the market. The report consists of quantitative and qualitative insights that have contributed to the market's growth.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2017-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2017-2021
Growth Rate	CAGR of 6.7% from 2023-2030
Unit	Value (USD million)
Segmentation	By Product Type Indwelling Catheters Intermittent Catheters External Catheters
By Material Latex Silicone Others
By Type Male Female
By End-user Hospitals & ASCs Clinics Long-term Care Centers Homecare Settings Others
By Country/Sub-region Austria Romania Hungary Poland Rest of Central Europe